Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Middlefield Banc Corp. to Farmers National Banc Corp. for 2.6 shares of Farmers common stock per share of Middlefield common stock [1] Company Summary - The transaction involves Middlefield Banc Corp. being sold to Farmers National Banc Corp. [1] - The exchange ratio for the sale is set at 2.6 shares of Farmers common stock for each share of Middlefield common stock [1] Legal Rights and Options - Halper Sadeh encourages Middlefield shareholders to explore their legal rights and options regarding the sale [1] - Shareholders can contact Halper Sadeh for more information on their rights [1]

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the proposed sale of Avadel Pharmaceuticals plc to Alkermes plc for Avadel shareholders [1] Transaction Details - The proposed transaction offers Avadel shareholders $18.50 per share [1] - Shareholders will also receive a non-transferable contingent value right that could provide an additional cash payment of $1.50 per share, contingent upon final FDA approval of LUMRYZ™ for the treatment of idiopathic conditions [1]

Core Viewpoint - Hologic, Inc. is undergoing a proposed sale to Blackstone and TPG, valued at up to $18.3 billion, which has led to a downgrade of its stock rating by William Blair from "Outperform" to "Market Perform" [1][2][6] Company Overview - Hologic, Inc. specializes in medical diagnostics and devices within the women's health sector [1] - The company is currently trading at $74.16, reflecting a 3.18% increase from the previous day [4] - Hologic's stock has fluctuated between a high of $84.39 and a low of $51.90 over the past year, with a market capitalization of approximately $16.49 billion [4][6] Acquisition Details - The proposed acquisition involves purchasing all outstanding shares of Hologic at $76 per share, with potential additional payments through a non-tradable contingent value right [2][3] - The deal offers Hologic shareholders a total of $76.00 per share in cash, plus up to $3.00 more through contingent value rights [2] Market Activity - Today's trading volume for Hologic is notably high at 13.85 million shares, indicating strong investor interest amid ongoing acquisition discussions [5][6]

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the proposed sale of Hologic, Inc. to funds managed by Blackstone and TPG for Hologic shareholders [1] Transaction Details - Hologic shareholders are set to receive $76.00 per share in cash [1] - Additionally, shareholders will receive a non-tradable contingent value right to receive up to $3.00 per share, payable in two installments of up to $1.50 each [1]

Group 1 - Halper Sadeh LLC is investigating TrueCar, Inc. for potential violations related to its sale to Fair Holdings, Inc. at $2.55 per share [1] - Hillenbrand, Inc. is under investigation for its sale to an affiliate of Lone Star Funds for $32.00 per share in cash [2] - The firm may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options without any out-of-pocket payment for legal fees [4] - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [4]

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of TrueCar, Inc. to Fair Holdings, Inc. at a price of $2.55 per share for TrueCar shareholders [1]. Group 1: Investigation Details - The investigation focuses on whether TrueCar and its board of directors violated federal securities laws or breached fiduciary duties by not obtaining the best possible consideration for shareholders [3]. - Concerns include whether Fair Holdings is underpaying for TrueCar and if all material information necessary for shareholders to assess the merger consideration has been disclosed [3]. Group 2: Potential Actions - On behalf of TrueCar shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures, and other relief related to the proposed transaction [4].

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PotlatchDeltic Corporation (NASDAQ: PCH) to Rayonier Inc. for 1.7339 common shares of Rayonier for each share of common stock of PotlatchDeltic is fair to PotlatchDeltic shareholders. Upon closing of the proposed transaction, PotlatchDeltic shareholders will own approximately 46% of the combined company. Halper Sadeh encourages PotlatchDeltic shareholders to click here to learn more ab. ...

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of substantially all assets of Lazydays Holdings, Inc. to CIRV Group, LLC and CIRV Group Real Estate Holdings, LLC for Lazydays shareholders [1] Company Investigation - The law firm is encouraging Lazydays shareholders to learn more about their legal rights and options regarding the asset sale [1] - Contact information for legal inquiries is provided, including names and phone numbers of representatives from Halper Sadeh [1]

Group 1 - Halper Sadeh LLC is investigating the fairness of the sale of SWK Holdings Corporation to Runway Growth Finance Corp for SWK shareholders [1] - The investigation focuses on whether SWK and its board of directors violated any legal obligations [1]

Core Insights - Akero Therapeutics is currently involved in a significant transaction with Novo Nordisk, which has attracted attention from law firms investigating potential legal violations and the fairness of the sale [1][5][6] Financial Overview - Canaccord Genuity has set a price target of $54 for Akero, which aligns with the trading price and the per-share sale price to Novo Nordisk, valuing Akero at approximately $4.7 billion [2][6] - The stock is trading at $54.25, reflecting a 16.68% increase or $7.76, indicating positive market sentiment towards the transaction [3][6] - Akero's market capitalization is approximately $4.34 billion, with a trading volume of 27.07 million shares [4] Legal and Regulatory Aspects - Investigations by Ademi Firm and Halper Sadeh LLC are focusing on potential breaches of fiduciary duty and the fairness of the proposed sale, raising questions about the implications for Akero's shareholders [5][6] - The transaction includes substantial benefits for Akero insiders and imposes penalties if Akero accepts a competing bid, which limits alternative transactions [4]